Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease

NCT01560754 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: nicotine transdermal patch

Sponsor

James BOYD MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]